This site is intended for health professionals only

Chickenpox added to list of notifiable diseases from April

Chickenpox added to list of notifiable diseases from April
By Anna Colivicchi
13 January 2025



Eight additional infectious diseases, including chickenpox, will be added to the list of notifiable diseases once new legislation comes into force on 6 April.

It follows a Government consultation to ensure that regulations ‘meet current surveillance needs’.

Last week, UKHSA laid out the changes in a webinar for GPs, explaining that it is ‘absolutely essential’ to have good surveillance systems in place for chickenpox to be able to monitor the effectiveness of a potential vaccine programme.

It comes after the Joint Committee on Vaccination and Immunisation (JCVI) recommended that a universal chickenpox vaccination programme is included in the routine childhood schedule.

But GPs raised concerns that having to report chickenpox will bring an increase in workload and that many cases could go undetected as patients ‘don’t usually go to a clinician with chickenpox’.

One GP attending the webinar described the change as ‘ridiculous’ and added: ‘This means every child will need reporting and many don’t present to the GP.’

Another GP said: ‘Could not the labs analyse the chickenpox immunity markers of cohorts of children instead of it being a GP task?’

According to the Government’s consultation response, published in December, only under half (47%) of those consulted thought chickenpox should be added to the list. Consulted parties raised concerns around the additional workload this could place on GP teams responsible for reporting notifiable diseases.

Eight new notifiable diseases

  • Middle East respiratory syndrome (MERS)
  • influenza of zoonotic origin
  • chickenpox (varicella)
  • congenital syphilis
  • neonatal herpes
  • acute flaccid paralysis or acute flaccid myelitis (AFP or AFM)
  • disseminated gonococcal infection (DGI)
  • Creutzfeldt-Jakob disease (CJD)

Source: Government consultation response

The Government said that, in response to these concerns, UKHSA conducted ‘further impact assessment’ on the impact of adding chickenpox on primary care workload and that they estimate the ‘overall burden’ for individual GP practices of this change ‘would be low’.

UKHSA is expecting less than 20 chickenpox notifications for an ‘average’ GP practice across the year, and said that this will ‘substantially decline’ once a vaccine programme is rolled out.

UKHSA’s consultant medical epidemiologist Gayatri Amirthalingam told the webinar: ‘With chickenpox, as it’s primarily a clinical diagnosis, we do not rely on laboratory confirmation.

‘We really do need good clinical notification systems, to be able to look at what the baseline burden of disease is and then be able to monitor the impact following a potential introduction of the vaccination programme.

‘I know some of you will be thinking this is going to add quite considerable burden in terms of your day to day activity.

‘I want to reassure you that as part of this process, there was an extensive assessment that was undertaken to try and understand what the burden of disease would be for individual practices, which actually at a practice level, was considered to be quite modest.’

A version of this story was first published on our sister title Pulse.

Want news like this straight to your inbox?

Related articles